These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22560326)

  • 1. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
    Liu X; Yu H; Yang L; Li C; Li L
    Eur J Cell Biol; 2012 Aug; 91(8):654-61. PubMed ID: 22560326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY; Kim HS
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues.
    Lappas M; Permezel M; Rice GE
    Placenta; 2006; 27(11-12):1060-72. PubMed ID: 16434095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2003 Mar; 302(2):415-20. PubMed ID: 12604364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells.
    Jung WK; Lee CM; Lee DS; Na G; Lee DY; Choi I; Park SG; Seo SK; Yang JW; Choi JS; Lee YM; Park WS; Choi IW
    Int J Mol Med; 2014 Feb; 33(2):449-56. PubMed ID: 24337644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
    Cheron A; Peltier J; Perez J; Bellocq A; Fouqueray B; Baud L
    J Immunol; 2004 Jun; 172(12):7677-83. PubMed ID: 15187150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxy-delta12,14-prostaglandin-J(2) up-regulates cyclooxygenase-2 but inhibits prostaglandin-E(2) production through a thiol antioxidant-sensitive mechanism.
    Reyes-Martin P; Ramirez-Rubio S; Parra-Cid T; Bienes-Martínez R; Lucio-Cazana J
    Pharmacol Res; 2008 May; 57(5):344-50. PubMed ID: 18456507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
    Wang JJ; Mak OT
    Prostaglandins Other Lipid Mediat; 2011 Apr; 94(3-4):104-11. PubMed ID: 21396480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone.
    Lappas M; Permezel M; Georgiou HM; Rice GE
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4667-72. PubMed ID: 12364456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
    Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
    Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
    Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon H; Um JW; Sohn J; Song GG; Ji JD
    Exp Mol Med; 2005 Jun; 37(3):179-85. PubMed ID: 16000871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2.
    Gong P; Stewart D; Hu B; Li N; Cook J; Nel A; Alam J
    Antioxid Redox Signal; 2002 Apr; 4(2):249-57. PubMed ID: 12006176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
    Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
    Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-deoxy-Δ12,14 -prostaglandin J2 reduces recruitment of bone marrow-derived monocyte/macrophages in chronic liver injury in mice.
    Han Z; Zhu T; Liu X; Li C; Yue S; Liu X; Yang L; Yang L; Li L
    Hepatology; 2012 Jul; 56(1):350-60. PubMed ID: 22371273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-Deoxy-Delta12,14-prostaglandin J(2) induces death receptor 5 expression through mRNA stabilization independently of PPARgamma and potentiates TRAIL-induced apoptosis.
    Nakata S; Yoshida T; Shiraishi T; Horinaka M; Kouhara J; Wakada M; Sakai T
    Mol Cancer Ther; 2006 Jul; 5(7):1827-35. PubMed ID: 16891469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
    Nie M; Corbett L; Knox AJ; Pang L
    J Biol Chem; 2005 Jan; 280(4):2550-61. PubMed ID: 15531761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
    Kim HY; Kim HK; Kim JR; Kim HS
    Immunol Cell Biol; 2005 Jun; 83(3):286-93. PubMed ID: 15877607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
    Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.